World Diabetes Day 2024: Simple ways to treat, prevent diabetic foot diseases and foot ulcers
Here's how diabetic foot diseases and foot ulcers are caused, who is at risk, signs to watch and expert tips to prevent or ...
Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy
On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD ...
Microbion reports topline data from Phase II study of DFI therapy
Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for diabetic ...
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs
Over 200 Unproven Skin Substitutes Will No Longer Be Covered Under Revised LCDs Company to Benefit from MACs’ Commitment to ...
MiMedx provided update on LCDs regarding skin substitute
MiMedx (MDXG) provided the following update on the Local Coverage Determinations, LCDs, regarding “Skin Substitute Grafts/Cellular and ...
The Pharma Letter11h
Positive results for Microbion’s new diabetic foot ulcer drug
Microbion's Phase II trial of pravibismane for diabetic foot ulcer infections showed strong safety and positive efficacy ...
Stockhead on MSN4d
Recce green lit to begin dosing in registrational Phase 3 trial for diabetic foot infections
Recce Pharmaceuticals has achieved a ‘landmark milestone’ with Human Research Ethics Committee approval received for its ...